How much funding has Freenome raised?

Freenome has raised $300.0M in total funding, most recently a Series D round.

Who are Freenome's investors?

Freenome's investors include Perceptive Advisors, RA Capital Management, Andreessen Horowitz, GV, Fidelity Management.

Where is Freenome headquartered?

Freenome is headquartered in South San Francisco, California, United States.

What industry is Freenome in?

Freenome operates in Artificial Intelligence, Healthcare, Biotech, Personal Healthcare.

How many employees does Freenome have?

Freenome has 501-1000 employees.

Freenome

Outpacing cancer starts with early detection

South San Francisco, United States · Founded 2014 · $300.0M raised

Artificial Intelligence

Healthcare

Biotech

Personal Healthcare

Headquarters: South San Francisco, California
Employees: 501–1000
Founded: 2014
Business Model: B2B

Website: freenome.com
Total Funding: $300.0M
Last Round: $300.0M Series DDec 2021
Rounds: 1

About

Freenome is a high-growth biotech company developing next-generation blood tests to detect cancer in its earliest, most treatable stages. Founded in 2014 and headquartered in Brisbane, California, Freenome uses a multiomics platform that analyzes genomic, epigenomic, and proteomic biomarkers—including tumor-derived cell-free DNA—combined with machine learning to produce actionable cancer screening results from a standard blood draw. The company's lead program targets colorectal cancer (PREEMPT CRC Study) with additional programs in lung and other cancers. In 2025, Freenome entered an exclusive license agreement with Exact Sciences for its colorectal cancer blood test and announced a $330M SPAC merger to go public.

Summary

Freenome is an Artificial Intelligence company based in South San Francisco, United States, founded in 2014. It has raised $300.0M in total across 1 round, most recently a $300.0M Series D round in Dec 2021. Investors include Perceptive Advisors, RA Capital Management and Andreessen Horowitz.

LinkedIn X (Twitter)GitHub